Corticotropin-Releasing Factor Antagonists: Therapeutic Potential in the Treatment of Affective Disorders

ISSN： 1172-7047

Source： CNS Drugs, Vol.12, Iss.2, 1999-08, pp. : 85-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Corticotropin-Releasing Factor Receptor Antagonists in Affective Disorders and Drug Dependence - An Update

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 2, 2006-04 ,pp. : 147-165

Bentham Science Publishers

Access to resources Recommend Favorite

The Corticotropin-Releasing Factor (CRF) Family of Neuropeptides in Inflammation: Potential Therapeutic Applications

Current Medicinal Chemistry, Vol. 12, Iss. 13, 2005-06 ,pp. : 1503-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Small molecule corticotropin-releasing factor antagonists

By Lanier Marion Williams John P

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1619-1630

Informa Healthcare

Access to resources Recommend Favorite

Pre-Clinical Evidence that Corticotropin-Releasing Factor (CRF) Receptor Antagonists are Promising Targets for Pharmacological Treatment of Alcoholism

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 1, 2010-03 ,pp. : 77-86

Bentham Science Publishers

Access to resources Recommend Favorite

The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders

By Grigoriadis Dimitri E

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 651-684

Informa Healthcare

Access to resources Recommend Favorite